Rajagopalan Murlidhar, Chatterjee Manas, De Abhishek, Dogra Sunil, Ganguly Satyaki, Kar Bikash Ranjan, Madnani Nina, Neema Shekhar, Parasramani S G, Patel Krina, Tahiliani Sushil
Department of Dermatology, Apollo Hospitals, Chennai, Tamil Nadu, India.
Department of Dermatology, Command Hospital, Kolkata, West Bengal, India.
Indian Dermatol Online J. 2021 Sep 10;12(5):674-682. doi: 10.4103/idoj.IDOJ_113_21. eCollection 2021 Sep-Oct.
Psoriasis is a common inflammatory disease with significant comorbidities, and regardless of its extent, it affects the patients' quality of life. The various modalities of treating psoriasis comprise topical or systemic medications, phototherapy, and an array of biologic agents. There is a lack of Indian recommendations on the management of psoriasis with these different modalities and challenges faced by the clinicians in day-to-day practice.
To develop India-specific consensus for systemic management of patients with moderate-to-severe psoriasis.
A panel of dermatology experts, based on the evidence and international recommendations, coupled with their own clinical experience, developed recommendations for systemic management of patients with moderate-to-severe psoriasis.
These recommendations are meant to provide guidance in terms of choice of systemic therapies, dosing, effectiveness, and safety. It also addresses clinical challenges that may be experienced during psoriasis management.
银屑病是一种常见的炎症性疾病，伴有多种严重的合并症，无论其严重程度如何，都会影响患者的生活质量。治疗银屑病的方法多种多样，包括局部或全身用药、光疗以及一系列生物制剂。目前缺乏关于印度采用这些不同治疗方法管理银屑病的建议，以及临床医生在日常实践中面临的挑战。
制定针对印度中重度银屑病患者系统管理的共识。
一组皮肤科专家基于证据和国际建议，并结合他们自己的临床经验，制定了中重度银屑病患者系统管理的建议。
这些建议旨在为系统治疗的选择、剂量、有效性和安全性提供指导。它还解决了银屑病管理过程中可能遇到的临床挑战。
